中国药房2016，Vol.27Issue(20)：2759-2761,2762,4.DOI:10.6039/j.issn.1001-0408.2016.20.07
重庆地区39家医院2012－2014年抗肿瘤基本药物使用分析
Analysis of the Application of Anti-tumor Essential Medicine in 39 Hospitals from Chongqing Area during 2012-2014
韩宪忠 1范炜 1金蜀蓉 1丁家昱 1黄堃2
作者信息
- 1. 重庆市人民医院药学部，重庆 400014
- 2. 上海市食品药品监督管理局科技情报研究所，上海 200040
- 折叠
摘要
Abstract
OBJECTIVE:To provide reference for rational use of anti-tumor essential medicine in the clinic. METHODS:The application of anti-tumor essential medicine in 39 hospitals from Chongqing area during 2012-2014 was analyzed statistically in re-spects of consumption sum,DDDs,DDC and B/A. RESULTS:The total consumption sum of anti-tumor essential medicine in 39 hospitals from Chongqing area during 2012-2014 increased from 10 083.65 ten thousand yuan to 15 186.65 ten thousand yuan,with annual increase rate of 22.72%. 3-year total consumption sum was 37 952.45 ten thousand yuan,and the sum of consumption sum of top 10 medicines was 36 742.24 ten thousand yuan,accounting for 96.81%;top 3 medicines were paclitaxel,oxaliplatin and flu-orouracil. During 2012-2014,DDDs had changed to certain extent,and the front medicines contained tegafur,paclitaxel and cyclo-phosphamide,etc;the most increment medicine was paclitaxel (oral),whose annual growth rate was 59.63%;that of tamoxifen decreased year by year,with annual decrease rate of 5.14%. DDC of paclitaxel,oxaliplatin and etoposide were the higher others. Annual B/A of oxaliplatin,fluorouracil and cytosine arabinoside were all lower than 1.00. CONCLUSIONS:The lonsumption sum and DDDs of anti-tumor essential medicine had increased reasonably in 39 hospitals from Chongqing area during 2012-2014,while their DDC had kept stable. Main medicines used in the clinic are suitable for numerous indications,and are expensive.关键词
抗肿瘤药/基本药物/销售金额/用药频度/用药分析Key words
Anti-tumor medicine/Essential medicine/Consumption sum/DDDs/Medication analysis分类
医药卫生引用本文复制引用
韩宪忠,范炜,金蜀蓉,丁家昱,黄堃..重庆地区39家医院2012－2014年抗肿瘤基本药物使用分析[J].中国药房,2016,27(20):2759-2761,2762,4.
